{
  "actions": [
    {
      "acted_at": "2022-01-18",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2022-01-18",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s3516-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "117",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2022-01-18",
  "number": "3516",
  "official_title": "A bill to require the Secretary of Health and Human Services to provide emergency use authorization with respect to certain COVID-19 diagnostic tests approved for use in the European Union.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Increase Access to COVID Testing Act",
  "sponsor": {
    "bioguide_id": "S001197",
    "district": null,
    "name": "Sasse, Ben",
    "state": "NE",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2022-01-18",
  "subjects": [
    "Cardiovascular and respiratory health",
    "Drug safety, medical device, and laboratory regulation",
    "Emergency medical services and trauma care",
    "Europe",
    "European Union",
    "Health",
    "Infectious and parasitic diseases",
    "Medical tests and diagnostic methods"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2022-01-18",
    "date": "2023-08-07T14:59:55Z",
    "text": "Increase Access to COVID Testing Act\n\nThis bill directs the Food and Drug Administration (FDA) to provide upon request emergency use authorization for COVID-19 rapid antigen tests approved for use in the European Union.\n\nDuring the declared COVID-19 public health emergency, the FDA shall grant emergency use authorization to a COVID-19 rapid antigen test upon a proper request by the test's manufacturer if (1) the test is on the European Commission Directorate-General for Health and Food Safety's common list for approved COVID-19 tests, and (2) the request is for the non-laboratory use of the test without a prescription.\n\nThe bill waives certain requirements for a request for emergency use authorization under this bill, such as a finding from the FDA that the test may be effective in diagnosing COVID-19.\n\nIf a test authorized under this bill is removed from the EU common list, the FDA must determine within 30 days of such removal whether the emergency use authorization for the test should continue."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Increase Access to COVID Testing Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Increase Access to COVID Testing Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to require the Secretary of Health and Human Services to provide emergency use authorization with respect to certain COVID-19 diagnostic tests approved for use in the European Union.",
      "type": "official"
    }
  ],
  "updated_at": "2023-08-07T15:00:31Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s3516.xml"
}